Shinji Noda
Shinji Noda
Verified email at
Cited by
Cited by
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
S Noda, M Suárez-Fariñas, B Ungar, SJ Kim, C de Guzman Strong, H Xu, ...
Journal of Allergy and Clinical Immunology 136 (5), 1254-1264, 2015
The translational revolution and use of biologics in patients with inflammatory skin diseases
S Noda, JG Krueger, E Guttman-Yassky
Journal of Allergy and Clinical Immunology 135 (2), 324-336, 2015
Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)+ TH2/TH1 cell imbalance, whereas adults acquire CLA+ TH22/TC22 cell subsets
T Czarnowicki, H Esaki, J Gonzalez, D Malajian, A Shemer, S Noda, ...
Journal of Allergy and Clinical Immunology 136 (4), 941-951. e3, 2015
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
M Suárez-Fariñas, B Ungar, S Noda, A Shroff, Y Mansouri, ...
Journal of Allergy and Clinical Immunology 136 (5), 1277-1287, 2015
Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis
T Taniguchi, Y Asano, K Akamata, S Noda, Y Masui, D Yamada, ...
The Journal of rheumatology 39 (3), 539-544, 2012
Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis
S Noda, Y Asano, S Nishimura, T Taniguchi, K Fujiu, I Manabe, ...
Nature communications 5 (1), 1-17, 2014
Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis
T Czarnowicki, J Gonzalez, KM Bonifacio, A Shemer, P Xiangyu, ...
Journal of Allergy and Clinical Immunology 137 (1), 118-129. e5, 2016
Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin‐Treated Fli‐1–Haploinsufficient Mice
T Taniguchi, Y Asano, K Akamata, S Noda, T Takahashi, Y Ichimura, ...
Arthritis & Rheumatology 67 (2), 517-526, 2015
Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling
DA Ewald, S Noda, M Oliva, T Litman, S Nakajima, X Li, H Xu, ...
Journal of Allergy and Clinical Immunology 139 (2), 562-571, 2017
Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma
T Takahashi, Y Asano, K Sugawara, T Yamashita, K Nakamura, ...
Journal of Experimental Medicine 214 (4), 1129-1151, 2017
Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
E Guttman-Yassky, B Ungar, S Noda, M Suprun, A Shroff, R Dutt, S Khattri, ...
Journal of Allergy and Clinical Immunology 137 (1), 301-304, 2016
Amelioration of tissue fibrosis by toll‐like receptor 4 knockout in murine models of systemic sclerosis
T Takahashi, Y Asano, Y Ichimura, T Toyama, T Taniguchi, S Noda, ...
Arthritis & rheumatology 67 (1), 254-265, 2015
Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis
Y Masui, Y Asano, S Shibata, S Noda, N Aozasa, K Akamata, D Yamada, ...
Journal of the European Academy of Dermatology and Venereology 26 (3), 354-360, 2012
Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis
Y Ichimura, Y Asano, K Akamata, T Takahashi, S Noda, T Taniguchi, ...
Archives of dermatological research 306 (4), 331-338, 2014
Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1
K Akamata, Y Asano, N Aozasa, S Noda, T Taniguchi, T Takahashi, ...
Arthritis Research & Therapy 16 (2), 1-14, 2014
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis
S Noda, Y Asano, T Takahashi, K Akamata, N Aozasa, T Taniguchi, ...
Rheumatology 52 (5), 790-799, 2013
Coating apparatus
Y Tanaka, S Noda
US Patent 4,480,583, 1984
Association of anti‐RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis
R Saigusa, Y Asano, K Nakamura, S Miura, Y Ichimura, T Takahashi, ...
The Journal of dermatology 42 (5), 524-527, 2015
Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis
K Akamata, Y Asano, T Taniguchi, T Yamashita, R Saigusa, K Nakamura, ...
Rheumatology 54 (7), 1308-1316, 2015
A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis
S Noda, Y Asano, K Akamata, N Aozasa, T Taniguchi, T Takahashi, ...
PLoS One 7 (2), e32272, 2012
The system can't perform the operation now. Try again later.
Articles 1–20